TEMPORARY TARGET GLUCOSE VALUES FOR TEMPORARY REDUCTIONS IN FLUID DELIVERY

Patent №

US 11,628,250

Granted

2023-04-18

Filed 2018

Owner

MEDTRONIC MINIMED, INC.

Lab

AI components

1

evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16156801

Techniques related to temporary setpoint values are disclosed. The techniques may involve causing operation of a fluid delivery device in a first mode for automatically delivering fluid to a patient based on a first target glucose value. Additionally, the techniques may involve obtaining a second target glucose value. The second target glucose value may be a temporary target glucose value to be used for a specified period of time to regulate fluid delivery to the patient, and the second target glucose value may be greater than the first target glucose value. The techniques may further involve causing, based on obtaining the second target glucose value, operation of the fluid delivery device in a second mode for automatically delivering fluid to the patient. The second mode may be for reduced fluid delivery during the specified period of time.

Evolutionary computationA61M 5/1723A61B 5/14503A61B 5/14532A61B 5/4839A61B 5/746A61M 5/14244G16H 20/17G16Z 99/00+4 more

AI classification

Evolutionary computation0.91
AI hardware0.26
Natural language0.01
Vision0.00
Knowledge representation0.00
Machine learning0.00
Planning0.00
Speech0.00

Ownership

MEDTRONIC MINIMED, INC.

assignment · 537640033

Assignors

GROSMAN, BENYAMIN, WU, DI, ROY, ANIRBAN, PARIKH, NEHA J.

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC